E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


A pharmacoeconomic study on cost variation of antiplatelet drugs available in Indian market

Ainsy Goldlin T J, Prakash M.

Abstract
Background: Expenditure spent on pharmaceutical products accounts for a significant percent of the total health-care expenses of any country. Hence, there is a need to prioritize different and sometimes competing health-care interventions or possibly different brands of a particular medicine, especially in case of chronic illnesses for countries with fixed resources. Pharmacoeconomics helps us to make such decisions. Since antiplatelet drugs are prescribed on long-term basis, they were included in this study.

Aim and Objective: The aim of this study was to analyze the cost variation of the antiplatelet drugs available in the market under various brand names manufactured by different pharmaceutical industries.

Materials and Methods: A cross-sectional study was conducted to analyze the cost variation of different antiplatelet drugs available in Indian market. Cost of each drug with respect to dosage and formulation was obtained from the “current index of medical specialties” website for India. Cost ratio and percentage cost variation were then calculated.

Results: Among the injectable and oral and drugs included in this study, the percentage cost variation was observed to be maximum with eptifibatide 75 mg vial, prasugrel 5 mg film-coated tablets, and aspirin-clopidogrel (75 + 75 mg) capsules.

Conclusion: Even though the cost variation is found to be wide among the antiplatelet drugs available in Indian market, getting a cost-effective drug is not building castles in the air for the beneficiaries. This could be rendered possible with the help of policy-makers, pharmaceutical companies, physicians, and pharmacists when they join hands together.

Key words: Pharmacoeconomics; Cost Variation; Antiplatelet Drugs


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ainsy Goldlin T J
Articles by Prakash M
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

J AGT, M P. A pharmacoeconomic study on cost variation of antiplatelet drugs available in Indian market. doi:10.5455/njppp.2020.10.01008202021052020


Web Style

J AGT, M P. A pharmacoeconomic study on cost variation of antiplatelet drugs available in Indian market. http://www.njppp.com/?mno=81951 [Access: June 03, 2020]. doi:10.5455/njppp.2020.10.01008202021052020


AMA (American Medical Association) Style

J AGT, M P. A pharmacoeconomic study on cost variation of antiplatelet drugs available in Indian market. doi:10.5455/njppp.2020.10.01008202021052020



Vancouver/ICMJE Style

J AGT, M P. A pharmacoeconomic study on cost variation of antiplatelet drugs available in Indian market. doi:10.5455/njppp.2020.10.01008202021052020



Harvard Style

J, A. G. T. & M, . P. (2020) A pharmacoeconomic study on cost variation of antiplatelet drugs available in Indian market. doi:10.5455/njppp.2020.10.01008202021052020



Turabian Style

J, Ainsy Goldlin T, and Prakash M. 2020. A pharmacoeconomic study on cost variation of antiplatelet drugs available in Indian market. doi:10.5455/njppp.2020.10.01008202021052020



Chicago Style

J, Ainsy Goldlin T, and Prakash M. "A pharmacoeconomic study on cost variation of antiplatelet drugs available in Indian market." doi:10.5455/njppp.2020.10.01008202021052020



MLA (The Modern Language Association) Style

J, Ainsy Goldlin T, and Prakash M. "A pharmacoeconomic study on cost variation of antiplatelet drugs available in Indian market." doi:10.5455/njppp.2020.10.01008202021052020



APA (American Psychological Association) Style

J, A. G. T. & M, . P. (2020) A pharmacoeconomic study on cost variation of antiplatelet drugs available in Indian market. doi:10.5455/njppp.2020.10.01008202021052020